2Jay H Ryu, Jeffrey L Lyers, Stephen J Swensen. Bronchiolar disorders.AmJ Respir Crit Care Med,2003,168:1 277-1 292.
3Kim CK, KimSW, KimJS,et al. Bronchiolitis obliterans in the 1990s in Korea and United States. Chest,2001,120:1101 - 1106.
4Markopoulo KD, Cool CD, Elliott TL, et al. Obliterative bronchiolitis:varying presentations and clinicopathological correlation. Eur Respir J,2002,19:20-30.
5Estenne M, Maurer JR,Boehler,et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant,2002,21:297 - 310.
6Krishnan P, Thachil R, Gillego V. Diffuse panbronchiolitis: a treatable sinobronchial disease in need of recognition in the United States. Chest,2002,121:659 - 661.
7Sugiyama Y. Diffuse panbronchiolitis. Clin Chest Med, 1993, 14:765 -772.
8Kadota J, Mukae H, Tomono K, et al. High concentrations of hetachemokines in BAL fluid of patients with diffuse panbronchiolitis. Chest,2001,120:602 - 607.
9Jun Tamaoki. The effects of macrolides on inflammatory cells. Chest,2004,125(2) :41 - 51.
10Niewoehner D, Klinerman J, Rice D. Pathologic changes in the peripheral airways of young cigarette smokers. N Engl J Med,1974,291:755-758.
